Imatinib Terminated Phase 2 Trials for Metastatic Melanoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00402662A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma